This review explores the multifaceted role of the canonical NF-κB signaling pathway in the context of obesity-induced inflammation, with particular emphasis on the molecular architecture, key regulatory components, clinically relevant biomarkers and potential therapeutic strategies. The gene discussed is NFKB1; the disease is Obesity.